Page last updated: 2024-10-18

dalteparin and Aphasia

dalteparin has been researched along with Aphasia in 2 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Aphasia: A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karapurkar, AP1
Singh, R1
Teelala, SM1
Lalla, R1
Lui, JK1
McIntosh, LJ1
Escobar Valle, J1
Stockl, T1
Summers, S1

Other Studies

2 other studies available for dalteparin and Aphasia

ArticleYear
Free-floating thrombus in a stenotic supraclinoid left internal carotid artery.
    BMJ case reports, 2016, Mar-30, Volume: 2016

    Topics: Aged; Anticoagulants; Aphasia; Carotid Artery, Internal; Carotid Stenosis; Enoxaparin; Female; Human

2016
Facial Drooping, Aphasia, and an Incidental Lung Mass in a Nonsmoker.
    Journal of intensive care medicine, 2017, Volume: 32, Issue:3

    Topics: Aged; Air Pollutants, Occupational; Anticoagulants; Aphasia; Atrial Flutter; Carcinoma, Squamous Cel

2017